Material changes and developments Give a brief account on the material changes and developments regarding the controlling power and the nature of business during the preceding year as well as the material
the year in which export branded sales excluding LQSF grew up, after dropping in the first three quarters. Export CMG sales decreased c.45% YoY, since there was some customer ending the distribution
economy for the first quarter of 2019 continued to expand driven mainly by domestic demands. Private consumption expanded in all categories supported by the improvement in purchasing power from the rise in
implemented in some areas and business activities contributed to economic recovery. Private consumption contracted in consistent with low purchasing power and confidence. Meanwhile, the tourism sector
liquidation process. 2. Investment in the power operator business in Philippines The meeting of the Board of the Directors of the Company held on January 26, 2017 has resolved to approve the purchase of the
0 2204 2616 191/43 CTI Tower 21st Floor, Ratchadapisek Road, Klongtoey Subdistrict, Klongtoey District, Bangkok, 10110 Tel. 0 2204 2601 Fax. 0 2204 2616 2. Investment in the power operator business in
Blue Fenix. Currently, Blue Finix is under the liquidation process. 2. Investment in the power operator business in Philippines The meeting of the Board of the Directors of the Company held on January 26
the approved person wishes to make an advertisement for an offer for sale of its shares by any method other than distribution of the prospectus, the advertisement shall be in accordance with the
shareholders and directors of Modern Pharma Company Limited are not Executive Committee and shareholders including those with controlling power in the company. Therefore, it is not considered a connected